Skip to main content
 
 

The GlobalReady CRO

GlobalReady the full-service biotech Contract Research Organisation
service for Australia and North America

Globally accepted data

Avance Clinical has a world-class reputation for quality data. There are currently more than 280 Phase III global trials that conducted their Phase I in Australia.

Rapid start-up

Avance Clinical can deliver Site Initiation Visit (SIV) and Study Start in 5 – 6 weeks. No IND required.

Extend budget by 43.5%

Avance Clinical can secure the maximum rebate on your clinical trial spend with the Australian Government clinical trial rebate program.

Latest technology

Avance Clinical invests heavily in industry-leading technology platforms to support speed, communications, and regulatory compliance. In-house Medidata-trained specialists.

Meet our team at the next industry conference/event   BOOK A MEETING

Latest news videos

The Contract Research Organization

Recent features and awards

Talk to our Team   CONTACT US

Established & Proven over two decades

Agile and solutions-focussed

Avance Clinical is the largest full-service Australian CRO delivering quality clinical trials with globally accepted data in Australia and New Zealand for international biotechs.

Frost & Sullivan awards

Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Best Practices Award recipient for the past two years, has been providing CRO services in the region for more than two decades.

The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Pre-clinical through to Phase 1 and 2

Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Avance Clinical delivers customized solutions designed around specific client needs rather than a one size fits all approach.

Technology

As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Experienced Team

More than 300 In-House CRO Specialists

Avance Clinical had its genesis in the University of South Australia in the early 1980s as the Center for Pharmaceutical Research, when a group of academic scientists began providing clinical research and bioanalytical services to the local pharmaceutical industry.

Since then, it has grown to become the leading mid-sized CRO servicing the international drug development industry.

Avance Clinical offers some of the most extensive in-house clinical services including:

  • ClinicReady – pre-clinical services
  • Clinical Monitoring Management
  • Data Management
  • eClinical Solutions
  • Safety and Pharmacovigilance
  • Medical Writing
  • Project Management
  • Statistics and Pharmacokinetics
  • Quality Assurance

Pre-clinical ClinicReady

The ClinicReady range of services constitutes a natural progression in Avance Clinical’s role as the premier provider of early drug development support to the biotechnology sector. The company recognizes the major challenges faced by small biotechnology companies, particularly start-up companies who seek to drive their novel therapeutics to demonstration of safety and preliminary clinical Proof of Concept.

 

Discover More

Medical Writing

The Avance Clinical biostatistics and pharmacokinetics experts provide specialist guidance for your clinical research trial design and analysis.

Discover More

Data Management

Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

Discover More

Safety and Pharmacovigilance

Clinical trials safety monitoring and reporting is vital to ensure participant safety, data integrity, and regulatory compliance.

Regulatory guidelines around clinical trial safety monitoring and reporting demand strict safety management procedures, from a highly-skilled, and experienced safety team.

Discover More

eClinical Solutions

The Avance Clinical team works with eClinical leaders such as Medrio, Medidata, and Oracle to offer regulatory compliant and patient-centric tools for rapid start-up and continual data flow.

Discover More

Quality Assurance

Data quality is at the heart of everything at Avance Clinical. Delivered by our highly experienced staff we support our clients with their clinical trial audit to achieve their quality objectives for their clinical research trials.

Discover More

Clinical Monitoring Management

Avance Clinical has experienced clinical monitoring staff across all phases of clinical trials and can collaboratively support the Australian CRO arm of multinational trials.

Discover More

Project Management

Avance Clinical provides each clinical research trial with a dedicated Project Manager to ensure that milestones are reached, timelines are met and that our clients receive effective communication and ongoing status reports.

Discover More

“It has been a great pleasure working with you on this project. Your flexibility, pragmatic approaches and focus on the work has been exceptional. I am looking forward to have the next compound entering the clinic with you.”

Head of Drug Discovery, Pharmaxis Ltd

“Working with the Avance Team has helped us to develop and complete high quality and compliant clinical studies. I especially appreciate their penchant for communication, quality and pragmatism.”

Sr. Vice President, Regulatory, Quality & Clinical Affairs, Atossa Genetics, Inc.

“Having conducted several Phase I studies in Australia it made sense to continue in the country with our Phase II program, particularly given the high-quality support we have received from our CRO.”

Atossa Therapeutics Inc.

“Avance Clinical has proven themselves to be my “Champions”, anticipating problems and always acting in the interest of getting the trial done professionally, resourcefully, and in alignment with the goals of the Sponsor and well-being of the volunteers.”

Chairman of the Board and Chief Medical Officer, BioFactura Inc

“Medrio has supported numerous study starts in Australia, over 150 with Avance Clinical alone, and we’re always impressed with the speed of their timelines.”

CEO Mike Novotny (former), Medrio

“We reached out to Avance to refine and polish a substantive and comprehensive drug study clinical trial ethics application. The Avance Team were remarkably quick to respond to our inquiry. Avance provided us within a very short turn-around period a comprehensive appraisal of the documentation covering all elements including protocol, ethics, investigator brochure and patient information and consent. Avance were highly engaged with the research investigator team and suggested changes were clear and well rationalized. The services provided were cost-effective and well justified. I have no hesitation to recommend Avance as a quality CRO”.

Curtin Health Innovation Research Institute
360
Studies in the past 5 years
300
Experienced Team Members
18,000
Participants past 5 years
26
Years of CRO experience

“This overall customer-first approach offers immense value to existing and new customers and solidifies
the company’s position in the market. Avance Clinical remains a trusted partner, earning a reputation for
delivering the overall best in the CRO industry. With its strong overall performance, Avance Clinical earns
Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award in the contract research organization industry.”

Azza Fazar,Best Practices Research Analyst, Frost & Sullivan

Latest News

View our latest client and company

February 22, 2024 in Company News

Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks

February 20, 2024 Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks Revolutionizing Clinical Research: Accelerate Innovation with GenAI by Ryght & Avance Clinical Laguna…
Read More
January 8, 2024 in Company News

Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner

Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner - Affecting Drug Development Schedules & Financial Plans Avance Clinical, the leading Australian and North American CRO…
Read More
November 17, 2023 in Company News

Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC

Adelaide, Australia | North Carolina, USA – Avance Clinical, the Australian and North American market-leading CRO for biotechs, has signed a strategic technology MOU with leading Korean decentralized clinical trials…
Read More
View All News

Partner with the GlobalReady Contract Research Organisation

Contact Us

DOWNLOAD OUR LATEST WHITEPAPER

Why 65% of US Biotechs Struggle to Identify Suitable CRO Partner

By filling in this form you consent to Avance Clinical contacting you. Read our Privacy Policy
This field is for validation purposes and should be left unchanged.

This will close in 0 seconds